Analyzing the Future of Polymerase Chain Reaction (PCR) Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the polymerase chain reaction (pcr) market grown in recent years?
In recent years, the market size for the polymerase chain reaction (PCR) has seen substantial growth. Forecasts predict expansion from $11.42 billion in 2024 up to $12.67 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to the growth during the historic period include a surge in research facilities, a rise in the count of patients with chronic and infectious diseases, an increment in the prevalence of genetic and chronic disorders, population growth, and an increase in the elderly population.
How is the polymerase chain reaction (pcr) market size expected to evolve during the forecast period?
The market size for Polymerase Chain Reaction (PCR) is projected to undergo a swift expansion in the coming years, escalating to a valuation of $18.97 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.6%. The anticipated surge throughout the forecast period is ascribed to escalating concern over food safety and an amplified demand for secure and superior quality food products. Furthermore, the mushrooming demand for molecular diagnostics and personalized medicine, coupled with increasing emphasis on digital Polymerase Chain Reaction (dPCR), is also fueling the market growth. Key trends expected to mold the market trajectory within the forecast timeframe encompass real-time PCR, DNA sequencing technologies, advancement in diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and innovation in advanced molecular diagnostic solutions.
Get your polymerase chain reaction (pcr) market report here!
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report
Which key drivers are propelling the polymerase chain reaction (pcr) market’s growth?
The growth of the polymerase chain reaction (PCR) market is anticipated to be propelled by the increasing demand for personalized medicine. Personalized medicine, also colloquially known as precision medicine, is a medical strategy that customizes healthcare choices, practices, techniques, and treatments to the unique characteristics of each patient. The need for personalized medicine is escalating due to improvements in data analytics, specific reactions to patient treatment, and the ability to customize therapies based on personal genetic profiles. PCR aids personalized medicine by allowing the amplification and examination of distinct genetic sequences, which gives clinicians the ability to modify treatment plans according to unique genetic make-up. For example, data from the Personalized Medicine Coalition, a professional membership organization in the US, indicated that in 2022, the approval of 12 new personalized medicines made up approximately 34% of all newly approved treatments, showing a significant rise from prior years. Consequently, the burgeoning demand for personalized medicine is catalyzing the expansion of the polymerase chain reaction market.
What are the market segments in the polymerase chain reaction (pcr) industry?
The polymerase chain reaction (PCR) market covered in this report is segmented –
1) By Type: Conventional Polymerase Chain Reaction, Other Types
2) By Indication: Infectious Diseases, Oncology, Genetic Disorders, Other Indications
3) By Application: Medical, Non-Medical
4) By End User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industries, Diagnostic Centers, Academic And Research Organization
Subsegments:
1) By Conventional Polymerase Chain Reaction: Endpoint Pcr, Gel Electrophoresis-Based Pcr, Reverse Transcription Pcr (Rt-Pcr), Quantitative Pcr (Qpcr) For Gene Expression, Nested Pcr
2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr), Digital Pcr (Dpcr), Multiplex Pcr, Reverse Transcription-Quantitative Pcr (Rt-Qpcr), Isothermal Amplification (Lamp), Next-Generation Pcr (Ngs-Based Pcr Techniques), High-Throughput Pcr
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp
Which leading companies are shaping the growth of the polymerase chain reaction (pcr) market?
Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics
Which trends are expected to transform the polymerase chain reaction (pcr) market?
Key players in the polymerase chain reaction market are striving to enhance genetic analysis accuracy, efficiency, and simplicity by developing real-time polymerase chain reaction (RT-PCR) test kits. RT-PCR is a laboratory-developed testing method used to amplify and measure specific DNA sequences in real time. For example, in November 2022, Xpert Xpress Multiplex Vaginal Panel (MVP), a multiplex PCR test that can identify DNA from three unique vaginal infections – bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis from a single vaginal swab, was released by Cepheid, a US molecular diagnostics company. Compared to conventional polymerase chain reaction methods, it offers real-time monitoring, quantification and improved sensitivity and specificity, making it a vital tool in molecular biology and clinical diagnostics.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15638
Which geographic areas are influencing the growth of the polymerase chain reaction (pcr) market?
North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Blockchain Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report
Blockchain In Banking And Financial Services Global Market Report 2024
Blockchain Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blockchain-ai-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
